Natural History of Complex Renal Cysts: Clinical Evidence Supporting Active Surveillance
Abstract
Purpose:
We evaluated intervention rates, progression and cancer specific survival outcomes in patients with complex renal cysts in a single center experience.
Materials and Methods:
We used the Montage™ radiology data mining system to retrospectively identify all reported cases of complex renal cyst at our institution from 2001 to 2013. The primary study end points were overall and cancer specific survival. The secondary end points included radiographic progression and upgrading, clinical progression and final histology on surgical pathology.
Results:
We identified 336 patients with a complex renal cyst, of whom 185 (55.1%), 122 (36.3%) and 29 (8.6%) had Bosniak IIF, III and IV cysts, respectively. Median followup was 67.1 months (range 34.4 to 101.6). In the 332 patients with followup there was 1 cancer specific death (0.3%) and overall mortality was 6.2%. Ten (5.4%), 37 (30.3%) and 18 patients (62.1%) with Bosniak IIF, III and IV, respectively, underwent surgical or ablative intervention. The indication for intervention was predominantly age (intervention vs no intervention mean ± SD age 50.1 ± 15.9 vs 62.5 ± 13.9 years) and complexity. Surgery with radical and partial nephrectomy (23 patients or 35% and 37 or 57%, respectively) was most common and favorable final pathology was identified. Two treated patients experienced recurrence during followup. When excluding patients with von Hippel-Lindau syndrome, the cancer specific survival rate was 100%.
Conclusions:
Cancer survival and overall survival in patients with Bosniak IIF to IV renal cysts was high with only 1 cancer specific death. No cancer deaths were recorded in patients who did not undergo intervention. Reconsidering management guidelines for complex renal cysts is warranted, particularly consideration for initial surveillance of Bosniak III cysts.
References
- 1 : Incidental finding of renal masses at unenhanced CT: prevalence and analysis of features for guiding management. AJR Am J Roentgenol2011; 197: 139. Google Scholar
- 2 : Evaluation and management of the renal mass. Med Clin North Am2011; 95: 179. Google Scholar
- 3 : Contemporary incidence and mortality rates of kidney cancer in the United States. Can Urol Assoc J2014; 8: 247. Google Scholar
- 4 : Cancer statistics, 2016. CA Cancer J Clin2016; 66: 7. Google Scholar
- 5 : Incidentalomas: initial management. Am Fam Physician2014; 90: 784. Google Scholar
- 6 : Incidence of malignancy in complex cystic renal masses (Bosniak category III): should imaging-guided biopsy precede surgery?. AJR Am J Roentgenol2003; 180: 755. Google Scholar
- 7 : Management of incidental renal masses: time to consider contrast-enhanced ultrasonography. Ultrasound2016; 24: 34. Google Scholar
- 8 : The current radiological approach to renal cysts. Radiology1986; 158: 1. Google Scholar
- 9 : An update of the Bosniak renal cyst classification system. Urology2005; 66: 484. Google Scholar
- 10 : Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography—a systematic review and meta-analysis. Eur Radiol2017; 27: 2239. Google Scholar
- 11 : Bosniak classification for complex renal cysts reevaluated: a systematic review. J Urol2017; 198: 12. Link, Google Scholar
- 12 : CUA guideline on the management of cystic renal lesions. Can Urol Assoc J2017; 11: E66. Google Scholar
- 13 : EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol2015; 67: 913. Google Scholar
- 14 : Bosniak category IIF and III cystic renal lesions: outcomes and associations. Radiology2012; 262: 152. Google Scholar
- 15 : Cystic renal cell carcinoma carries an excellent prognosis regardless of tumor size. Urol Oncol2015; 33: 505.e509. Google Scholar
- 16 : Natural history of renal angiomyolipoma (AML): most patients with large AMLs >4cm can be offered active surveillance as an initial management strategy. Eur Urol2016; 70: 85. Google Scholar
- 17 : Management of small renal masses: American Society of Clinical Oncology clinical practice guideline summary. J Oncol Pract2017; 13: 276. Google Scholar
- 18 : Management of small renal masses: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol2017; 35: 668. Google Scholar
- 19 : Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol2016; 69: 660. Google Scholar
- 20 : Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings. J Urol2015; 193: 1899. Link, Google Scholar
- 21 : Multilocular cystic renal cell carcinoma: pathological T staging makes no difference to favorable outcomes and should be reclassified. J Urol2016; 196: 1350. Link, Google Scholar
- 22 : Bosniak category IIF designation and surgery for complex renal cysts. J Urol2009; 182: 1091. Link, Google Scholar
